Home
Live Updates
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Q2 2023 Earnings Call Transcript : comparemela.com
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Q2 2023 Earnings Call Transcript
Operator: Good morning, everyone. And welcome to the Deciphera Pharmaceuticals Second Quarter 2023 Financial Results Conference Call. Today’s call is being recorded.
Related Keywords
Spain ,
Italy ,
United Kingdom ,
Singapore ,
China ,
France ,
Germany ,
Canada ,
Canadian ,
Peter Lawson ,
Tucker Kelly ,
Reni Benjamin ,
Brad Canino ,
Jen Larson ,
Matt Sherman ,
Chris Raymond ,
Dan Martin ,
Michael Schmidt ,
Dan Flynn ,
Eun Yang ,
Tyler Van Buren ,
Steve Hoerter ,
Piper Sandler ,
Margarida Duarte ,
Andrew Berens ,
Research Engine ,
Incyte Corporation ,
Nasdaq ,
Zai Lab ,
Barclays ,
Pfizer ,
Head Of International ,
Deciphera Pharmaceuticals Second Quarter ,
Canadian Pharmaceutical Alliance ,
Deciphera Pharmaceuticals Inc ,
Deciphera Pharmaceuticals ,
Call Transcript August ,
Results Conference ,
Senior Vice President ,
Chief Executive Officer ,
Chief Commercial Officer ,
Chief Medical Officer ,
Chief Financial ,
Safe Harbor ,
Private Securities Litigation Reform Act ,
Supplemental New Drug Application ,
American Association ,
Cancer Research Annual Meeting ,
Kinase Switch Control Research Engine ,
Chief Scientific Officer ,
Switch Control Kinase Inhibition ,
Dash Dhanak ,
Executive Vice President ,
Chief Scientific ,
Chief Financial Officer ,
Inflation Reduction ,
Official Gazette ,
Van Buren ,
Zai Labs ,
comparemela.com © 2020. All Rights Reserved.